Synergy Pharmaceuticals committee of equity security holders named

By Sarah Lizee

Olympia, Wash., Jan. 29 – Synergy Pharmaceuticals Inc.’s official committee of equity security holders was appointed Tuesday by Region 2 U.S. trustee William K. Harrington, according to a notice filed with the U.S. Bankruptcy Court for the Southern District of New York.

The committee members are Samuel Goldstein of Laguna Beach, Calif.; Jerome Lewis Jennings of Burnee, Ill.; John J. Sastry of Chesterfield, Mo.; Michael L. Meyer of Newport Beach, Calif.; Dorin Toderas of Cluj-Napoca, Romania; Rohit Sharma of Philadelphia; and Logan J. Reed of Branford, Conn.

Synergy is a New York-based biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies. The company filed bankruptcy on Dec. 12, 2018 under Chapter 11 case number 18-14010.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.